ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,273
Screening encounters
5,107
Diagnostic referrals
968
Outstanding pathways
323

Screening pathway

  1. Screening5,107Encounters
  2. Positive finding1,762Documented findings
  3. Referral968Diagnostic referrals
  4. Follow-up1,168Diagnostic visits
  5. Outcome645Resolved pathways

Stage totals use different units. Pending pathways: 323. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0342 · EXP-0342Synthetic · Site D

Full participant history through 2027-02-10, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-02-06
  4. · Diagnostic referral · EXP-0342-T-R
  5. · Contact attempt · Unsuccessful
  6. · Diagnostic booking · Initial booking
  7. · Contact attempt · Reached
  8. · Diagnostic visit · Attended
  9. · Diagnosis · Colposcopy · Biopsy collected
  10. · Diagnosis · Histopathology · No high-grade lesion identified
  11. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2026-10-01
  12. · Follow-up disposition · Resolved · EXP-0342-T-R
  13. · Screening · HPV DNA · Repeat · Prior VIA positive
  14. · Screening result · HPV DNA · HPV detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

4273 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0320 · Expanded synthetic participant 0320Site D — Community Engagement Programme
EXP-0322 · Expanded synthetic participant 0322Site B — Peri-Urban Access Programme
EXP-0323 · Expanded synthetic participant 0323Site B — Peri-Urban Access Programme
EXP-0324 · Expanded synthetic participant 0324Site A — Urban Referral Hub
EXP-0325 · Expanded synthetic participant 0325Site A — Urban Referral Hub
EXP-0326 · Expanded synthetic participant 0326Site D — Community Engagement Programme
EXP-0327 · Expanded synthetic participant 0327Site E — Resource-Constrained Navigation Programme
EXP-0328 · Expanded synthetic participant 0328Site A — Urban Referral Hub
EXP-0329 · Expanded synthetic participant 0329Site D — Community Engagement Programme
EXP-0330 · Expanded synthetic participant 0330Site B — Peri-Urban Access Programme
EXP-0331 · Expanded synthetic participant 0331Site A — Urban Referral Hub
EXP-0333 · Expanded synthetic participant 0333Site E — Resource-Constrained Navigation Programme
EXP-0335 · Expanded synthetic participant 0335Site A — Urban Referral Hub
EXP-0336 · Expanded synthetic participant 0336Site C — Rural Outreach Programme
EXP-0337 · Expanded synthetic participant 0337Site B — Peri-Urban Access Programme
EXP-0338 · Expanded synthetic participant 0338Site C — Rural Outreach Programme
EXP-0339 · Expanded synthetic participant 0339Site D — Community Engagement Programme
EXP-0341 · Expanded synthetic participant 0341Site C — Rural Outreach Programme
EXP-0342 · Expanded synthetic participant 0342Site D — Community Engagement Programme
EXP-0343 · Expanded synthetic participant 0343Site A — Urban Referral Hub
EXP-0344 · Expanded synthetic participant 0344Site A — Urban Referral Hub
EXP-0345 · Expanded synthetic participant 0345Site D — Community Engagement Programme
EXP-0346 · Expanded synthetic participant 0346Site E — Resource-Constrained Navigation Programme
EXP-0347 · Expanded synthetic participant 0347Site C — Rural Outreach Programme
EXP-0348 · Expanded synthetic participant 0348Site E — Resource-Constrained Navigation Programme

Programme insights

Encounters by modality

VIA
1930
HPV DNA
2465
Cytology
712

Navigation activity

Barrier documented
875
Contact attempt
1410
Navigation intervention
381
Diagnostic booking
1206
Diagnostic visit
1168

Documented barriers

Contact difficulty
281
Transport difficulty
287
Appointment coordination
307

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.